We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,141

Arkansas' New Telemedicine Rules a Small Step Forward
  • Foley & Lardner LLP
  • USA
  • August 25 2016

The Arkansas Legislative Council's Rules and Regulations Subcommittee approved, on August 16, 2016, proposed regulations which, if accepted by the


Federal Circuit Affirms Tygacil Formulation Patent
  • Foley & Lardner LLP
  • USA
  • August 23 2016

In Apotex, Inc. v. Wyeth LLC, the Federal Circuit affirmed the decision of the USPTO Patent Trial and Appeal Board (PTAB) finding that Apotex had


Missouri Governor Signs New Telemedicine Law
  • Foley & Lardner LLP
  • USA
  • August 23 2016

Missouri's governor signed into law SB 579 (the "Act"), on June 8, 2016, establishing new telemedicine practice standards, including explicitly


HRSA Proposes Administrative Process to Resolve Disputes Between 340B Program Covered Entities and Drug Manufacturers
  • Foley & Lardner LLP
  • USA
  • August 22 2016

Taking a step toward completing a requirement imposed by the Affordable Care Act, the federal government has proposed regulations that would create


USPTO announces cancer moonshot challenge
  • Foley & Lardner LLP
  • USA
  • August 22 2016

The USPTO announced a public challenge in support of the National Cancer Moonshot Initiative. The USPTO is asking the public to investigate and


Construing Markush Group Claims
  • Foley & Lardner LLP
  • USA
  • August 16 2016

In Multilayer Stretch Cling Film v. Berry Plastics, the Federal Circuit provided a detailed discussion of the construction of claims that use Markush


South Carolina Enacts New Telemedicine Law: What You Should Know
  • Foley & Lardner LLP
  • USA
  • August 10 2016

South Carolina Governor, Nikki Haley signed the South Carolina Telemedicine Act (S.B. 1035) into law, on June 3, 2016, establishing new telemedicine


AbbVie Sues Amgen On 10 Of 100 Humira Patents
  • Foley & Lardner LLP
  • USA
  • August 9 2016

On August 4, 2016, AbbVie Inc. filed a complaint against Amgen, Inc. under the Biologics Price Competition and Innovation Act (BPCIA), asserting that


FDA Issues Guidance on Use of Public Human Genetic Variant Databases and Their Use in Personalized Medicine
  • Foley & Lardner LLP
  • USA
  • August 4 2016

Next Generation Sequencing (NGS) permits the analysis of millions of genetic variants at a time and has proven to be invaluable for the development


USPTO Launches Patents 4 Patients
  • Foley & Lardner LLP
  • USA
  • August 2 2016

To support the National Cancer Moonshot initiative, the USPTO has launched the Patents 4 Patients program, also known as the Cancer Immunotherapy